Chong Kun Dang, Institutional Investors Net Sell 124,566 Shares Over Last 5 Days... Stock Price 223,000 KRW (-2.41%)

As of 9:30 AM on the 15th, Chong Kun Dang is trading at 223,000 KRW, down 2.41% from the previous day. The trading volume is 188,008 shares, which is about 6.21% of the previous day's volume. Chong Kun Dang is known as a leading pharmaceutical company in the industry, focusing on therapeutics.

On January 13, Hana Financial Investment researcher Sun Min-jung estimated that "Operating profit in 2021 is expected to slightly decrease compared to the previous year to around 130 billion KRW due to a high base last year and increased marketing expenses returning to normal levels. This year's top-line growth is also expected to be in the high single digits as the growth of major products slows somewhat. However, the growth of new products like Qsymia, which achieved quarterly sales of over 5 billion KRW within one year of launch, deserves attention. There is excessive optimism regarding COVID-19 therapeutics." She set the target price for Chong Kun Dang at 250,000 KRW.

Over the past five days, individual investors have net purchased 122,248 shares of Chong Kun Dang, while foreigners and institutions have net purchased 5,237 shares and net sold 124,566 shares, respectively.

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.